{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-24-000018","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.283702+00:00","generated_at":"2026-06-05T10:16:51.823545+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Integra LifeSciences CEO Jan De Witte to retire by end of 2024; Stuart Essig named Executive Chairman","bullets":["Jan De Witte to retire as President and CEO by end of 2024 after successor appointed; will remain until transition.","Stuart Essig, current Chairman, appointed Executive Chairman effective immediately to lead transition.","Board engaged Heidrick & Struggles to search for new CEO candidate; expects to appoint successor by end of 2024.","De Witte to serve as Senior Advisor from transition date through March 2026 under consulting agreement with base salary and bonus eligibility.","De Witte's retirement is for personal reasons, not due to disagreement with company operations or policies."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-24-000018","json":"https://secwatch.observer/filing/0000917520-24-000018.json","markdown":"https://secwatch.observer/filing/0000917520-24-000018.md","text":"https://secwatch.observer/filing/0000917520-24-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/iart-20240227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T10:16:51.823545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27a6f5f94e","claim":"Stuart M. Essig was appointed as Executive Chairman at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"On February 27, 2024, the Company’s Board of Directors appointed Stuart M. Essig, Ph.D., the Company’s Chairman, to the role of Executive Chairman, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"6a5018bfb5","claim":"Jan De Witte departed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"On February 27, 2024, Jan De Witte informed Integra LifeSciences Holdings Corporation (the “Company”) of his intention to retire from his position as President and Chief Executive Officer and director of the Company following the completion of a succession process.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}